Cumberland Pharmaceuticals (CPIX) Misses Q3 EPS by 10c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of $0.01, $0.10 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $10.4 million versus the consensus estimate of $12.65 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
• Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
• Ulta Beauty beats estimates as sales rise, shares gain